BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32486486)

  • 1. Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract.
    Sakaguchi D; Miyado K; Iwamoto T; Okada H; Yoshida K; Kang W; Suzuki M; Yoshida M; Kawano N
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility.
    Kawano N; Yoshida M
    Biol Reprod; 2007 Mar; 76(3):353-61. PubMed ID: 17123940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interacting proteins on human spermatozoa: adaptive evolution of the binding of semenogelin I to EPPIN.
    Silva EJ; Hamil KG; O'Rand MG
    PLoS One; 2013; 8(12):e82014. PubMed ID: 24312623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of recombinant human semenogelin as an inhibitor of human sperm motility.
    Mitra A; Richardson RT; O'Rand MG
    Biol Reprod; 2010 Mar; 82(3):489-96. PubMed ID: 19889947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seminal vesicle protein SVS2 is required for sperm survival in the uterus.
    Kawano N; Araki N; Yoshida K; Hibino T; Ohnami N; Makino M; Kanai S; Hasuwa H; Yoshida M; Miyado K; Umezawa A
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4145-50. PubMed ID: 24591616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal vesicle secretory protein 7, PATE4, is not required for sperm function but for copulatory plug formation to ensure fecundity†.
    Noda T; Fujihara Y; Matsumura T; Oura S; Kobayashi S; Ikawa M
    Biol Reprod; 2019 Apr; 100(4):1035-1045. PubMed ID: 30452524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of calcium in human spermatozoa via EPPIN, the semenogelin receptor.
    O'Rand MG; Widgren EE
    Biol Reprod; 2012 Feb; 86(2):55. PubMed ID: 22075473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of a Seminal Gene Cluster Reinforces a Crucial Role of SVS2 in Male Fertility.
    Shindo M; Inui M; Kang W; Tamano M; Tingwei C; Takada S; Hibino T; Yoshida M; Yoshida K; Okada H; Iwamoto T; Miyado K; Kawano N
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.
    Anamthathmakula P; Erickson JA; Winuthayanon W
    Biol Reprod; 2022 May; 106(5):879-887. PubMed ID: 35098308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seminal vesicle secretion 2 acts as a protectant of sperm sterols and prevents ectopic sperm capacitation in mice.
    Araki N; Trencsényi G; Krasznai ZT; Nizsalóczki E; Sakamoto A; Kawano N; Miyado K; Yoshida K; Yoshida M
    Biol Reprod; 2015 Jan; 92(1):8. PubMed ID: 25395676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seminal vesicle proteins SVS3 and SVS4 facilitate SVS2 effect on sperm capacitation.
    Araki N; Kawano N; Kang W; Miyado K; Yoshida K; Yoshida M
    Reproduction; 2016 Oct; 152(4):313-21. PubMed ID: 27486266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies, immunofluorometric assay, and detection of human semenogelin in male reproductive tract: no association with in vitro fertilizing capacity of sperm.
    Koistinen H; Soini T; Leinonen J; Hyden-Granskog C; Salo J; Halttunen M; Stenman UH; Seppälä M; Koistinen R
    Biol Reprod; 2002 Mar; 66(3):624-8. PubMed ID: 11870067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of miR-525-3p and its target gene SEMG1 in the spermatozoa of patients with asthenozoospermia.
    Zhou QZ; Guo XB; Zhang WS; Zhou JH; Yang C; Bian J; Chen MK; Guo WB; Wang P; Qi T; Wang CY; Yang JK; Liu CD
    Andrology; 2019 Mar; 7(2):220-227. PubMed ID: 30575326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epididymal protease inhibitor (EPPIN) is a protein hub for seminal vesicle-secreted protein SVS2 binding in mouse spermatozoa.
    Mariani NAP; Camara AC; Silva AAS; Raimundo TRF; Andrade JJ; Andrade AD; Rossini BC; Marino CL; Kushima H; Santos LD; Silva EJR
    Mol Cell Endocrinol; 2020 Apr; 506():110754. PubMed ID: 32044375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility.
    Fritz R; Mukherjee A; Zaghi S; Agalliu I; Jindal S; Tashima AK; Fricker LD; Davies KP
    J Assist Reprod Genet; 2019 Sep; 36(9):1891-1900. PubMed ID: 31346917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epididymal Binder of SPerm genes and proteins: what do we know a decade later?
    Plante G; Manjunath P
    Andrology; 2015 Sep; 3(5):817-24. PubMed ID: 26236016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seminal plasma effects on sperm handling and female fertility.
    Maxwell WM; de Graaf SP; Ghaoui Rel-H; Evans G
    Soc Reprod Fertil Suppl; 2007; 64():13-38. PubMed ID: 17491139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
    Robert M; Gagnon C
    Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GPI-anchored CD52 antigen of the sperm surface interacts with semenogelin and participates in clot formation and liquefaction of human semen.
    Flori F; Ermini L; La Sala GB; Nicoli A; Capone A; Focarelli R; Rosati F; Giovampaola CD
    Mol Reprod Dev; 2008 Feb; 75(2):326-35. PubMed ID: 17624925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Semenogelin and sperm motility inhibition: an update].
    Yi C; He RS; Zhao H; Hao LN
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):1023-6. PubMed ID: 21218648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.